The historic procedure was performed in Texas on a 45-year-old patient who had been hospitalized for months with advanced heart failure.

The device covers three vessels at once and can be deployed through the patient's TAVR access site. Researchers shared their first-in-human experience in JACC: Case Reports.

Kenneth Margulies, MD, will be the group's next president. These new terms all begin after the HFSA Annual Scientific Meeting in September.

The STS Risk Calculator App, available on both iOS and Android devices, gives users improved access to real-time risk assessments.

The first 250 patients has been enrolled in the CORCINCH-HF U.S. pivotal trial evaluating the AccuCinch Transcatheter Left Ventricular Restoration System in patients with HFrEF.

The news is related to an earlier recall of more than 316,000 Medtronic devices.

Suman Tandon, MD, a representative of the American Society of Nuclear Cardiology, explains her organization's concerns about artificial intelligence being used to automatically deny prior authorizations and prevent patients from accessing care.

Sola is a rupture-resistant balloon catheter that uses laser energy to deliver 360-degree pressure with each pulse. It was designed to address limitations the company saw in current calcium-modification devices.

However, eligibility alone does not mean a patient will benefit from treatment.

Former American College of Cardiology president Kim Allan Williams, Sr., MD, an ACC delegate to the American Medical Association House of Delegates, discusses an AMA resolution aimed at improving public awareness of low-dose CT lung cancer exams that can screen for coronary artery calcium at the same time. 

The designation was awarded to a research team from China, who analyzed the efficacy of a novel radiotracer developed to target expression of the PD-L1 protein in suspected head and neck cancers. 

Recent advances in imaging technology have built on the momentum DBT utilization has created for early diagnoses.